Citation tools

Araki, Eiichi et al "Effects of Pemafibrate, a Novel Selective PPARα Modulator, on Lipid and Glucose Metabolism in Patients With Type 2 Diabetes and Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial." Diabetes Care 41.3 (2018): 538-546. Web. 03 Mar. 2021.